Myeloma in the Octogenarians: Disease Characteristics and Clinical Outcomes in the Era of Modern Anti-Myeloma Therapy

被引：0
|
作者：
Dimopoulos, Meletios A. [1 ]
Terpos, Evangelos [1 ]
Gavriatopoulou, Maria [1 ]
Kalapanida, Despoina [1 ]
Eleutherakis-Papaiakovou, Evangelos [1 ]
Roussou, Maria [1 ]
Mparmparoussi, Despoina [2 ]
Zomas, Athanasios [3 ]
Gika, Dimitra [1 ]
Kartasis, Zafiris [4 ]
Matsouka, Charis [2 ]
Kostis, Evangelos [1 ]
Kontogiannis, Sofoklis [1 ]
Konstantopoulos, Kostas [1 ]
Kastritis, Efstathios [1 ]
机构：
[1] Univ Athens, Sch Med, Athens 11528, Greece
[2] Alexandra Gen Hosp, Athens, Greece
[3] St Anargiri Canc Hosp, Athens, Greece
[4] Gen Hosp Chalkida, Chalkida, Greece
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
    Rajshekhar Chakraborty
    Lisa Rybicki
    Jason Valent
    Alex V. Mejia Garcia
    Beth M. Faiman
    Jack Khouri
    Christy J. Samaras
    Faiz Anwer
    Alok A. Khorana
    Blood Cancer Journal, 11
  • [2] Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
    Chakraborty, Rajshekhar
    Rybicki, Lisa
    Valent, Jason
    Garcia, Alex V. Mejia
    Faiman, Beth M.
    Khouri, Jack
    Samaras, Christy J.
    Anwer, Faiz
    Khorana, Alok A.
    BLOOD CANCER JOURNAL, 2021, 11 (06)
  • [3] Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
    Jumpei Teramachi
    Hirokazu Miki
    Shingen Nakamura
    Masahiro Hiasa
    Takeshi Harada
    Masahiro Abe
    Journal of Bone and Mineral Metabolism, 2023, 41 : 388 - 403
  • [4] Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
    Teramachi, Jumpei
    Miki, Hirokazu
    Nakamura, Shingen
    Hiasa, Masahiro
    Harada, Takeshi
    Abe, Masahiro
    JOURNAL OF BONE AND MINERAL METABOLISM, 2023, 41 (03) : 388 - 403
  • [5] Improved Outcomes of Myeloma Cast Nephropathy in Newly Diagnosed Multiple Myeloma With Modern Anti-Myeloma Therapies
    Hughes, Michael Sang
    Balev, Metodi
    Radhakrishnan, Jai
    Bhutani, Divaya
    Mapara, Markus
    Lentzsch, Suzanne
    Chakraborty, Rajshekhar
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025,
  • [6] Impact of bisphosphonate and anti-myeloma therapy on bone turnover markers in multiple myeloma
    Jandial, A.
    Hj, S.
    Mishra, K.
    Bhadada, S.
    Sood, A.
    Prakash, M.
    Meshram, A.
    Sandal, R.
    Lad, D.
    Aggarwal, R.
    Prakash, G.
    Vikas, S.
    Khadwal, A. R.
    Kumari, S.
    Varma, N.
    Varma, S. C.
    Malhotra, P.
    ANNALS OF ONCOLOGY, 2018, 29 : 370 - 370
  • [7] Anti-myeloma Effect of Xanthohumol on Multiple Myeloma Cells
    Tucker, Michael
    Rayalam, Srujana
    Wang, Xinyu
    FASEB JOURNAL, 2020, 34
  • [8] ANTI-MYELOMA EFFECT OF CANNABINOIDS
    Barbado, V.
    Medrano, M.
    Caballero-Velazquez, T.
    Alvarez-Laderas, I.
    Sanchez-Abarca, L. I.
    Garcia-Guerreo, E.
    Martin-Sanchez, J.
    Rosado, I. V.
    Gonzalez-Naranjo, P.
    Campillo, N.
    Piruat, J. I.
    Paez, J. A.
    Perez-Simon, J. A.
    HAEMATOLOGICA, 2016, 101 : 515 - 516
  • [9] Novel Anti-Myeloma Agents and Bone Metabolism: Implications in the Management of Myeloma Bone Disease
    Terpos, Evangelos
    Christoulas, Dimitrios
    Kastritis, Efstathios
    Migkou, Magda
    Gavriatopoulou, Maria
    Dimopoulos, Meletios-Athanassios
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S30 - S32
  • [10] Invasive Pulmonary Aspergillosis in Multiple Myeloma patients: A sizeable diagnosis in the era of novel anti-myeloma therapies
    Fuchs, Eyal
    Lavi, Noa
    Carasso, Yariv
    Oren, Ilana
    Hardak, Emilia
    MYCOSES, 2021, 64 (10) : 1298 - 1303
12345